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Abstract
!
The present study focused on the investigation of
the inhibition of cyclooxygenase-2 and nuclear
factor kappa B1 gene expression, nitric oxide
production, leukotriene biosynthesis (5-lipoxyge-
nase), and cyclooxygenase-1 and cyclooxygenase-
2 enzymes of Onopordum acanthium, and the iso-
lation and identification of its active compounds.
From the chloroform soluble part of the MeOH
extract prepared from aerial parts, lignans [pinor-
esinol (1), syringaresinol (2), and medioresinol
(3)] and flavonoids [hispidulin (4), nepetin (5),
apigenin (6), and luteolin (7)] were isolated by a
combination of different chromatographic meth-
ods. The structures of the compounds were deter-
mined by means of mass spectrometry and 1D-
and 2D‑nuclear magnetic resonance spectrosco-
py, and by comparison of the spectral data with
literature values. Extracts of different polarity
and the isolated compounds obtained from the
aerial parts, together with those previously iso-
lated from the roots of the plant [4β,15-dihydro-
3-dehydrozaluzanin C (8), zaluzanin C (9),
4β,15,11β,13-tetrahydrozaluzanin C (10), nitida-
nin diisovalerianate (11), 24-methylenecholester-
ol (12), and 13-oxo-9Z,11E-octadecadienoic acid
(13)], were evaluated for their inhibitory effects
on cyclooxygenase-2 and nuclear factor kappa B1
gene expression, inducible nitric oxide synthase,
5-lipoxygenase, and cyclooxygenase-1 and cyclo-
oxygenase-2 enzymes in in vitro assays. It was
found that O. acanthium extracts exert strong in-
hibitory activities in vitro and some lignans, flavo-
noids, and sesquiterpenes may play a role in these
activities. 4β,15-Dihydro-3-dehydrozaluzanin C
and zaluzanin C at 20 µM were the most active
constituents tested against lipopolysaccharide/in-
terferon-γ-induced nitric oxide production
(100.4 ± 0.5% and 99.4 ± 0.8%) in the inhibition of
cyclooxygenase-2 (98.6 ± 0.2% and 97.0 ± 1.1%)
and nuclear factor kappa B1 gene expression
(76.7 ± 7.3% and 69.9 ± 3.4%). Furthermore, it was
shown that these inhibitory effects are not due to
cytotoxicity of the compounds.
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l.Introduction
!
Onopordum is a large genus in the tribe Cardueae
(Asteraceae), which contains about 50 biennial
species. These plants are distributed in the Medi-
terranean area of Europe, northern Africa, the
Canary Islands, the Caucasus, and southwest and
central Asia [1,2]. Characteristic metabolites of
the genus Onopordum are flavonoids, acetylenic
compounds, steroids, triterpenes, lipids, and ni-
trogen-containing compounds. Moreover, differ-
ent germacrane-, elemane-, eudesmane-, and
guaiane-type sesquiterpenoids were identified in
the species, which possess a number of biological
activities (antibacterial, antifungal, antioxidant,
anti-inflammatory, and cytotoxic activities) [1].lanta Med 2015; 81: 1270–1276Onopordum acanthium L., commonly named
Scotch thistle, is a medicinal plant belonging to
the genus Onopordum that is naturalized in vari-
ous parts of Europe and Asia. The plant has been
used traditionally for its antibacterial, cardioton-
ic, hemostatic, hypotensive, and anticancer prop-
erties [3,4]. On the other hand, the inflorescences,
roots, seeds, and late developing leaves of O.
acanthium are used internally in the traditional
medicine of Central Asia for the treatment of in-
flammation of the bladder and the respiratory
and urinary systems [5]. Phytochemical studies
revealed the presence of sesquiterpenes, flavo-
noids, triterpenes, sterols, lipids, nitrogen-con-
taining compounds, phenolic acids, and couma-
rins in this species [1]. Pharmacological investiga-
tions revealed its antioxidant, angiotensin-con-
Table 1 Inhibition of COX-2 and NF-κB1 gene expression, NO production, 5-LOX, and COX-1 and COX-2 enzymes by extracts from herbs of O. acanthium. N = two
experiments in duplicate.
Extract Inhibition % ± SD
COX-2*
(10 µg/mL)
NF-κB1
(10 µg/mL)
iNOS
(10 µg/mL)
5-LOX
(50 µg/mL)
COX-1
(50 µg/mL)
COX-2**
(50 µg/mL)
n-Hexane extract of the aerial parts (A) 18.5 ± 17.9 < 10 16.9 ± 13.8 57.2 ± 2.8 40.5 ± 9.1 82.8 ± 8.4
Chloroform extract of the aerial parts (B) 41.8 ± 8.3 21.8 ± 6.7 76.7 ± 7.0 62.6 ± 6.9 < 10 61.8 ± 9.0
Aqueous-methanol extract of aerial parts (C) < 10 < 10 10.2 ± 6.0 31.2 ± 7.6 < 10 < 10
Dexamethasone*** 47.6 ± 4.2 ND ND ND ND ND
Quercetin*** ND 46.0 ± 8.4 ND ND ND ND
L-NMMA*** ND ND 52.2 ± 4.9 ND ND ND
Zileuton*** ND ND ND 63.0 ± 3.8 ND ND
Indomethacin*** ND ND ND ND 32.3 ± 4.8 ND
NS-398*** ND ND ND ND ND 30.5 ± 3.1
* COX-2 gene expression inhibition; ** COX-2 enzyme inhibition; *** positive control; ND = not determined
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l.verting enzyme (ACE) inhibitory activities and the ability to acti-
vate natural killer cells in vitro against tumor cells [6,7]. For-
merly, the antiproliferative activities of extracts prepared from
roots and aerial parts with solvents of different polarity were
evaluated on three human tumor cell lines (HeLa, MCF7, and
A431), and the chemical investigation of the roots resulted in
the isolation of sesquiterpene lactones, a neolignane, steroids,
and fatty acids. Some of the isolated compounds were responsi-
ble for the antiproliferative activity of O. acanthium [8,9].
As a continuation of phytochemical and pharmacological analy-
ses of O. acanthium, the isolation, identification of bioactive com-
pounds, and evaluation of in vitro inhibitory activity of the ex-
tracts and compounds from the aerial parts of O. acanthium on
cyclooxygenase-2 (COX-2) and nuclear factor kappa B1 (NF-κB1)
gene expression, inducible nitric oxide synthase (iNOS), 5-lipoxy-
genase (5-LOX), and cyclooxygenase-1 (COX-1) and COX-2 en-
zymes assays are reported in the present paper. The in vitro as-
says carried out on O. acanthium have not been performed previ-
ously. In addition, the cytotoxic activity of the compounds pos-
sessing COX-2 and NF-κB1 gene expression inhibitory effects
was also evaluated by the XTT assay at different time points in
various concentrations.D
ow
nl
oa
dResults and Discussion
!
Dried and ground aerial parts of O. acanthium were extracted
with MeOH. After concentration, the extracts were dissolved in
50% aqueous MeOH, and a solvent-solvent partition was per-
formed first with n-hexane (A) and then with CHCl3 (B), and the
residue gave the aqueous-MeOH extract (C). In preliminary test-
ings, COX-2 and NF-κB1 gene expression, iNOS, 5-LOX, and COX-1
and COX-2 inhibitory activities of these extracts were analyzed.
Extract B, which showed marked inhibitory activity in three test
systems (l" Table 1), was fractionated by vacuum liquid chroma-
tography (VLC) on silica gel, resulting in six main fractions (BI–
VI). These fractions were further evaluated for their inhibitory ef-
fects. Fractions BI, BIV, and BV demonstrated significant or mod-
erate activity against lipopolysaccharide (LPS)/interferon-γ (IFN-
γ)-induced nitric oxide (NO) production as well as the inhibition
of COX-2 gene expression and the COX-2 enzyme [inhibition of
iNOS (62.5 ± 16.5%, 102.0 ± 0.3%, and 79.9 ± 6.2%, respectively),
inhibition of COX-2 gene expression (45.5 ± 8.3%, 31.5 ± 11.1%,and 12.6 ± 5.7%, respectively), and inhibition of the COX-2 en-
zyme (63.8 ± 9.8%, 19.9 ± 8.4%, and 44.9 ± 8.8%, respectively)].
Fraction BI was separated by column chromatography (CC) on
polyamide to give seven subfractions (BI/1-I/7), and some of
them were found to be moderately or highly active on investi-
gated assays. The most active subfractions BI/2 (inhibition of
COX-2: 73.3 ± 3.7%; and NF-κB1 gene expression: 56.4 ± 2.1%; in-
hibition of iNOS: 103.1 ± 2.4%), BI/6 (inhibition of iNOS: 66.2 ±
12.2%) and BI/7 (inhibition of iNOS: 73.4 ± 4.4%) were then sub-
jected to multiple chromatographic separations, including VLC,
rotation planar chromatography (RPC), medium-pressure liquid
chromatography (MPLC), gel filtration on Sephadex LH-20, and
preparative thin-layer chromatography TLC. This purification
process afforded the isolation of seven compounds (1–7) in pure
form.
The structure elucidation was carried out by extensive spectro-
scopic analysis using one- and two-dimensional NMR (1H-1H
COSY, HSQC, HMBC) spectroscopy, atmospheric pressure chemi-
cal ionization-mass spectrometry (APCI‑MS) experiments, and
comparison of the spectral data with literature data. Three lig-
nans, pinoresinol (1), medioresinol (3) [10], and (±)-syringaresi-
nol (2) [11], and four flavonoids, hispidulin (4) [12], nepetin (5)
[13], apigenin (6), and luteolin (7), were identified from the aerial
parts of O. acanthium (l" Fig. 1). The compounds, excluding api-
genin (6) and luteolin (7), were isolated for the first time from
this species. Furthermore, pinoresinol (1), syringaresinol (2), his-
pidulin (4), and nepetin (5) were previously described from other
Onopordum species [1] and medioresinol (3) was first detected in
the genus.
The compounds isolated from aerial parts were tested for inhib-
itory effects on COX-2 and NFκB1 gene expression, iNOS, 5-LOX,
and COX-1 and COX-2 enzymes in in vitro assays at 20 µM con-
centration (l" Table 2). Among the flavonoids, noteworthy inhib-
itory activities (> 50% inhibition) were recorded for luteolin (7),
nepetin (5), and hispidulin (4). Luteolin (7) was the most potent
in the inhibition of 5-LOX (74.6 ± 8.8%) in accordance with previ-
ously reported studies [14]. Moreover, luteolin (7) was moder-
ately active on the COX-2 and NF-κB1 gene expression and iNOS
assays.
Only moderate activities were observed for the lignans, but pi-
noresinol (1) proved to be active against LPS/IFN-γ-induced NO
production. These results were in agreement with data published
by Jung et al., who investigated the inhibition of inflammatory
responses by pinoresinol (1) from the fruits of Forsythia koreanaLajter I et al. Inhibition of COX-2… Planta Med 2015; 81: 1270–1276
Table 2 Inhibition of COX-2 and NF-κB1 gene expression, NO production, 5-LOX, and COX-1 and COX-2 enzymes by compounds isolated from herbs of O.
acanthium. N = two experiments in duplicate.
Compound Inhibition % ± SD
COX-2*
(20 µM)
NF-κB1
(20 µM)
iNOS
(20 µM)
5-LOX
(20 µM)
COX-1
(20 µM)
COX-2**
(20 µM)
Pinoresinol (1) < 10 < 10 49.13 ± 4.10 37.5 ± 12.2 12.7 ± 6.1 12.3 ± 9.5
Syringarsinol (2) < 10 16.1 ± 11.5 17.44 ± 8.28 28.5 ± 7.1 < 10 < 10
Medioresinol (3) < 10 11.2 ± 7.7 < 10 11.4 ± 12.0 16.2 ± 8.1 < 10
Hispidulin (4) < 10 10.3 ± 1.9 < 10 51.6 ± 11.0 10.9 ± 2.5 < 10
Nepetin (5) 21.1 ± 23.4 10.9 ± 5.7 < 10 62.4 ± 7.7 < 10 10.1 ± 7.2
Apigenin (6) 30.4 ± 12.6 28.6 ± 8.2 21.6 ± 7.7 41.3 ± 10.2 < 10 24.3 ± 10.3
Luteolin (7) 37.2 ± 25.1 30.9 ± 1.0 38.9 ± 10.1 74.6 ± 8.8 10.2 ± 9.4 39.1 ± 10.8
Dexamethasone*** 47.6 ± 4.2 ND ND ND ND ND
Quercetin*** ND 46.0 ± 8.4 ND ND ND ND
L-NMMA*** ND ND 52.5 ± 4.9 ND ND ND
Zileuton*** ND ND ND 63.0 ± 3.8 ND ND
Indomethacin*** ND ND ND ND 32.3 ± 4.8 ND
NS-398*** ND ND ND ND ND 30.5 ± 3.1
* COX-2 gene expression inhibition; ** COX-2 enzyme inhibition; *** positive control; ND = not determined
Fig. 1 Structures of compounds 1–13.
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Table 3 Inhibition of COX-2 and NF-κB1 gene expression, NO production, 5-LOX, and COX-1 and COX-2 enzymes by extracts from roots of O. acanthium. N = two
experiments in duplicate.
Extract Inhibition % ± SD
COX-2*
(10 µg/mL)
NF-κB1
(10 µg/mL)
iNOS
(10 µg/mL)
5-LOX
(50 µg/mL)
COX-1
(50 µg/mL)
COX-2**
(50 µg/mL)
n-Hexane extract of the roots (A) 60.6 ± 7.9 17.5 ± 7.6 83.2 ± 1.1 66.9 ± 10.0 60.3 ± 8.4 86.5 ± 8.9
Chloroform extract of the roots (B) 53.7 ± 8.5 21.0 ± 6.8 51.8 ± 1.7 56.7 ± 8.1 < 10 31.8 ± 10.5
Aqueous-methanol extract of the
roots (C)
3.2 ± 6.2 10.0 ± 3.6 < 10 59.7 ± 7.7 < 10 28.5 ± 10.3
Dexamethasone*** 47.6 ± 4.2 ND ND ND ND ND
Quercetin*** ND 46.0 ± 8.4 ND ND ND ND
L-NMMA*** ND ND 52.5 ± 4.9 ND ND ND
Zileuton*** ND ND ND 63.0 ± 3.8 ND ND
Indomethacin*** ND ND ND ND 32.3 ± 4.8 ND
NS-398*** ND ND ND ND ND 30.5 ± 3.1
* COX-2 gene expression inhibition; ** COX-2 enzyme inhibition; *** positive control; ND = not determined
Table 4 Inhibition of COX-2 and NF-κB1 gene expression, NO production, 5-LOX, and COX-1 and COX-2 enzymes by compounds isolated from roots of O.
acanthium. N = two experiments in duplicate.
Compound Inhibition % ± SD
COX-2*
(20 µM)
NF-ĸB1
(20 µM)
iNOS
(20 µM)
5-LOX
(20 µM)
COX-1
(20 µM)
COX-2**
(20 µM)
4β,15-Dihydro-3-dehydrozaluzanin C (8) 98.6 ± 0.2 78.7 ± 7.3 100.4 ± 0.5 26.4 ± 12.9 < 10 10.5 ± 10.3
Zaluzanin C (9) 97.0 ± 1.1 69.9 ± 3.4 99.4 ± 0.8 < 10 < 10 < 10
4β,15,11β,13-Tetrahydrozaluzanin C (10) < 10 < 10 61.4 ± 17.3 < 10 < 10 29.5 ± 9.6
Nitidanin diisovalerianate (11) < 10 13.1 ± 14.6 < 10 16.1 ± 11.0 < 10 < 10
24-Methylenecolesterol (12) < 10 11.7 ± 10.6 < 10 < 10 10.1 ± 6.3 36.4 ± 9.5
13-Oxo-9Z,11E-octadecadienoic acid (13) < 10 18.6 ± 6.6 < 10 20.4 ± 11.5 16.4 ± 5.5 16.6 ± 8.8
Dexamethasone*** 47.6 ± 4.2 ND ND ND ND ND
Quercetin*** ND 46.0 ± 8.4 ND ND ND ND
L-NMMA*** ND ND 52.5 ± 4.9 ND ND ND
Zileuton*** ND ND ND 63.0 ± 3.8 ND ND
Indomethacin*** ND ND ND ND 32.3 ± 4.8 ND
NS-398*** ND ND ND ND ND 30.5 ± 3.1
* COX-2 gene expression inhibition, ** COX-2 enzyme inhibition, *** positive control, ND = not determined
Table 5 Inhibition of COX-2 and NF-κB1 gene expression inTHP-1 cells by iso-
lated compounds (8,9) from roots at various concentrations.
Compound Inhibition % ± SD
COX-2 gene
expression
NF-κB1 gene
expression
8 1 µM 41.6 ± 7.6 1 µM 19.3 ± 2.7
5 µM 79.7 ± 14.8 10 µM 54.3 ± 8.3
10 µM 96.0 ± 2.1 40 µM 91.2 ± 0.1
9 1 µM 19.4 ± 22.6 1 µM 13.5 ± 5.2
5 µM 51.9 ± 17.6 10 µM 44.6 ± 4.7
10 µM 83.7 ± 0.8 40 µM 87.9 ± 0.0
References* 47.6 ± 4.2 ND
ND 46.0 ± 8.4
* Dexamethasone at 2.5 nM (COX-2 gene expression); quercetin at 25 µM (NF-κB1
gene expression); ND = not determined
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l.(Rehder) Nakai (Oleaceae). Pinoresinol (1) inhibited the prod-
uction of NO, prostaglandin-E2 (PGE2), tumor necrosis factor-α,
and interleukin-6 in LPS-activated microglia. Furthermore, pi-
noresinol (1) attenuated mRNA and protein levels of iNOS, COX-
2, and proinflammatory cytokines in LPS activation [15].
Besides the extracts and compounds of the aerial parts of O.
acanthium, extracts of different polarity prepared from the roots
were also tested for their inhibitory effect on all test models
(l" Table 3). The n-hexane and CHCl3 extracts of the roots showed
a considerable inhibiting effect on more tests, therefore, the com-
pounds 8–13 isolated earlier from the lipophilic extract [9] were
also included in the assays. The most active compounds were
4β,15-dihydro-3-dehydrozaluzanin C (8) and zaluzanin C (9),
which exhibited inhibitory activities on the gene expression of
COX-2 and NF-κB1, and decreased the NO production at different
concentrations (l" Tables 4 and 5). These results confirm the pre-
viously reported anti-inflammatory activities of compounds 8
and 9 [1]. 4β,15,11β,13-Tetrahydrozaluzanin C (10) also demon-
strated activity against LPS/IFN-γ-induced NO production. Other
tested compounds were found to be moderately active or inactive
in the used assays. As far as we know, this is the first report on
inhibitory activity of compounds 8 and 9 against COX-2 and NF-
κB1 gene expression (mRNA level) in THP-1 cells.In order to determine whether the gene expression inhibitory ef-
fects were due to cytotoxicity, the compounds were investigated
by the XTT assay at different time points (4 h, 24 h, 48 h, 72 h) and
at different concentrations. It was found that the active com-
pounds had no or low effects on cell viability at the tested con-
centrations (l" Fig. 2).Lajter I et al. Inhibition of COX-2… Planta Med 2015; 81: 1270–1276
Fig. 2 Effects of 4β,15-dihydro-3-dehydrozaluza-
nin C (8) and zaluzanin C (9) in different concentra-
tions on human leukemia cell lines (THP-1). Effect
after 4 h, 24 h, 48 h, and 72 h using the XTT assay
(n = 6, mean ± SD). Vehicle-treated cells (crtl, 0.1%
DMSO) served as a control; vinblastin as a positive
control (0.1 µg/mL).
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l.Previously, the phytochemical investigation of another Onopor-
dum species (O. laconicum Heldr. & Sart. ex Rouy) also resulted
in the isolation of 4β,15-dihydro-3-dehydrozaluzanin C (8) and
zaluzanin C (9) [16], which were the most effective compounds
in our assays. The presence of these compounds is limited to
these species in the Onopordum genus. Furthermore other me-
tabolites, e.g., flavonoids [apigenin (6), luteolin (7), hispidulin
(4), and eriodictyol], were also found in both plant species [1].
Similarities in the phytochemical profile confirm the close rela-
tionship of these two species. The anti-inflammatory activity of
O. laconicum has not been investigated yet, but it can be promis-
ing for pharmacological examination from this point of view.
In summary, the present study reveals the in vitro COX-2 and NF-
κB1 gene expression, iNOS, 5-LOX, and COX-1 and COX-2 en-
zymes inhibitory effects of O. acanthium. The inhibitory activities
of the isolated compounds were demonstrated in these assays.
The results confirm that the inhibitory activities of the extracts
may be attributed mainly to flavonoids, lignans. and sesquiterpe-
noids, and other compounds are exerting additional effects. The
traditional uses of O. acanthium in ethnomedicine against in-
flammatory diseases seems to be supported by our data.Materials and Methods
!
General experimental procedures
VLCwas carried out on silica gel G (15 µm, Merck); CC on polyam-
ide (ICN) and Sephadex LH-20 (25–100 µm, Pharmacia Fine
Chemicals); preparative TLC on silica gel 60 F254 plates (Merck);
and RPC on silica gel 60 GF254 and Al2O3 60G (Merck) using a
Chromatotron instrument (Model 8924, Harrison Research).
MPLC was performed by a Büchi apparatus (Büchi Labortechnik
AG) using a 40 × 150mm RP18ec column (40–63 µm, Büchi).
NMR spectra were recorded on a Bruker Avance DRX 500 spec-
trometer at 500MHz (1H) and 125MHz (13C). The signals of the
deuterated solvents were taken as a reference. Two-dimensionalLajter I et al. Inhibition of COX-2… Planta Med 2015; 81: 1270–1276(2D) experiments were performed with standard Bruker soft-
ware. In the COSY, HSQC, and HMBC experiments, gradient-en-
hanced versions were used. MS spectra were recorded on an API
2000 Triple Quad mass spectrometer with an APCI ion source us-
ing positive and negative polarities.
Plant material
The roots and aerial parts of O. acanthiumwere collected in 2008
from the Southern Great Plain, Hungary, and identified by Dr.
Tamás Rédei (Institute of Ecology and Botany, Centre for Ecologi-
cal Research, Hungarian Academy of Sciences, Vácrátót, Hun-
gary). A voucher specimen (No. 814) has been deposited at the
Department of Pharmacognosy, University of Szeged.
Extraction and isolation
The air-dried and ground aerial parts of O. acanthium (4.4 kg)
were extracted with MeOH (61 L) at room temperature in a per-
colator. The crude extract (1550 g) was evaporated in vacuo and
subjected to solvent-solvent partitioning first with 30 L of n-hex-
ane (A) and then with 29 L of CHCl3 (B). The residue gave the
aqueous-MeOH exract (C). After concentration, the CHCl3 extract
(66 g) was fractionated by VLC on silica gel (85mm× 210mm),
which was eluted with a gradient system of n-hexane-CHCl3-
MeOH [from 7:3 :0 to 0:4:6 (600mL, 400mL, 500mL, 500mL,
2000mL, 1400mL, 1400mL, 1000mL 1000mL, 500mL, and
500mL, respectively), and finally MeOH (1500mL); the volumes
of collected fractions were 200mL and 100mL to yield six major
fractions (BI‑VI).
Fraction BI (12 g) was chromatographed on a polyamide column
(60mm× 200mm) with mixtures of MeOH and H2O [1:4, 2 :3,
3 :2, 4 :1, 9 :1 and 1:0 (1500mL each); the volume of collected
fractions was 500mL] as eluents to give seven fractions (BI/1–7).
Fraction BI/2 (1.26 g) was separated by VLC (45mm× 200mm)
with a gradient system of cyclohexane-EtOAc-MeOH [from
8:2:0 to 0:8:2 (260mL, 200mL, 300mL, 200mL, 300mL,
200mL, and 200mL, respectively) and MeOH (300mL; the vol-
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l.ume of collected fractions was 20mL] to yield eleven subfractions
(BI/2/1–11). The BI/2/5 subfraction (79.5mg) was further puri-
fied by RPC on Al2O3 (plates of 1mm thickness) with mixtures of
cyclohexane-CH2Cl2-MeOH [5:15:1 (100mL); the volume of col-
lected fractions was 2mL], and finally subjected to preparative
NP‑TLC using the mobile phase of cyclohexane-EtOAc-EtOH
(15:15:2) to yield compound 1 (5.5mg). Moreover, subfraction
B/I/2/6 (244.4mg) was separated by RP-MPLC with a gradient
system of MeOH‑H2O [from 1:1 to 9:1 (100mL each) and MeOH
(150mL); the volume of collected fractions was 10mL] and then
by preparative TLC, using cyclohexane-EtOAc-EtOH (15:15:2), to
give compounds 2 (9.4mg) and 3 (3.4mg).
Fraction BI/6 (1.1 g), which was eluted with MeOH‑H2O (4:1),
was separated by RPC on silica gel (plates of 4mm thickness)
with a gradient system of n-hexane-CH2Cl2-MeOH [2:7:1
(250mL), 2 :8 :1.5 (100mL) and MeOH (150mL); the volume of
collected fractions was 25mL] to yield two subfractions (BI/6/1
and BI/6/2). Subfraction BI/6/1 (102.5mg) was purified on Sepha-
dex LH-20 column using MeOH as an eluent to afford compound
4 (3.5mg). Furthermore, subfraction BI/6/2 (310mg) was sepa-
rated by RPC on silica gel (plates of 2mm thickness) with the iso-
cratic solvent system of CH2Cl2-MeOH [9:1 (500mL); the volume
of collected fractions was 30mL], and it was finally purified by a
Sephadex LH-20 column using the mobile phase MeOH [(70mL);
the volume of collected fractions was 2mL] to yield compound 5
(8mg).
Fraction BI/7 (637mg)was subjected to RPC on silica gel (plates of
4mm thickness) using a gradient system of cyclohexane-CH2Cl2-
MeOH [from 2:9:0.5 to 0:10:1 (80mL, 360mL, and 120mL, re-
spectively) andMeOH (120mL); the volume of collected fractions
was 40mL]. Two subfractions, BI/7/2 (111.5mg) and BI/7/3
(90mg), were chromatographed on a Sephadex LH-20 column
using the mobile phase MeOH [(70mL); the volume of collected
fractions was 2mL] to get compounds 6 (4.5mg) and 7 (4.5mg),
which were identified by co-TLC with authentic samples and via
1H- and 13C‑NMR spectroscopy as apigenin and luteolin, respec-
tively.
Compounds 8–13were previously published from the roots of O.
acanthium [9]. The purity of all isolated compounds was deter-
mined by integration of proton resonances, and was shown to
be 1–8 and 12: > 98%, 9–11 and 13: > 90%.
(+)-Pinoresinol (1): amorphous powder; [α]D24 + 53 (c 0.1, CHCl3);
1H‑NMR δH: (CDCl3): 3.10 (2 H, m, H-8, H-8′), 3.88 (2 H, dd, J = 9.1,
3.4 Hz, H-9a, H-9′a), 3.90 (6 H, s, 2 × OCH3), 4.25 (2 H, dd, J = 9.1,
6.8 Hz, H-9b, H-9′b), 4.74 (2 H, d, J = 4.1 Hz, H-7, H-7′), 6.81 (2 H,
dd, J = 8.2, 1.6, H-6, H-6′), 6.89 (2 H, d, J = 8.2, H-5, H-5′), 6.90
(2 H, d, J = 1.6, H-2, H-2′). 13C‑NMR δC: 54.2 (C-8, C-8′), 55.9
(OCH3), 71.7 (C-9, C-9′), 85.9 (C-7, C-7′), 108.6 (C-2, C-2′), 114.3
(C-5, C-5′), 120.7 (C-6, C-6′), 132.9 (C-1, C-1′), 145.3 (C-4, C-4′),
146.7 (C-3, C.-3′); APCI‑MS (negative mode): m/z 357 [M – H]−,
151, 136.
Pharmacological tests
Cell culture: The human monocytic cell line THP-1 was obtained
from European Collection of Cell Cultures (Item No: 88081201)
and was maintained in RPMI 1640 (Gibco®) supplemented with
2mM L-glutamine, 10% fetal bovine serum (Gibco®), 10mM
HEPES (Gibco®), 100 U/mL penicillin, and 100 µg/mL streptomy-
cin (Gibco®) at 5% CO2 and a 37°C humidified atmosphere.
NF-κB1/COX-2 gene expression assay: For the monocyte macro-
phage differentiation, 1 × 106/mL cells were seeded into a 24-well
plate with medium containing 12 nM phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich) for 48 h [17,18]. Subsequently, cells
were incubated with testing samples in a selected concentration
for 1 h and stimulated with 7.5 ng/mL LPS (Sigma-Aldrich) for an
additional 3 h [17]. The final concentration of the tested com-
pounds was 20 µM and the extracts were 10 µg/mL, which were
dissolved in DMSO. IC50 determinations of compounds 8 and 11
were performed in at least five concentrations, each in at least
three independent experiments run in duplicate. Positive con-
trols were quercetin (25 µM, purity ≥ 98%) (Sigma-Aldrich) for
NF-κB1 and dexamethasone (2.5 nM, purity ≥ 97%) (Sigma-Al-
drich) for COX-2. 0.1% DMSO was used as a calibrator sample.
RNA isolation and reverse transcription: Total RNA was extracted
with a GenElute™ Mammalian Total RNA Miniprep Kit (Sigma-
Aldrich). Reverse transcription was performed with a high-ca-
pacity cDNA Revers Transcription Kit (Applied Biosystems®). Both
were carried out according to themanufacturerʼs manual. The cy-
cler condition for reverse transcription was set to 25°C for
25min, 37°C for 120min, and 85°C for 5 s.
Real-time PCR: Primers and probes for NF-κB1 (NM_003998) and
COX-2 (NM_000963) were designed with Primer Express Soft-
ware supplied by Applied Biosystems® (COX-2 primers: forward
5′-GAA-TCATTC‑ACC‑AGG‑CAA‑ATT‑G-3′, reverse 5′-TCT‑GTA-
CTG‑CGG‑GTG‑GAA‑CA‑3′ and COX-2 probe: 5′-FAM‑TCC‑TAC-
CAC‑CAG‑CAA‑CCC‑TGC‑CA-TAMRA‑3′; NF-κB1 primers: for-
ward 5′-CCA‑CAG-ATGTTC‑ATA‑GAC‑AAT‑TTG‑C‑3′, reverse 5′-
TTC‑ACT‑AGT‑TTC‑CAA‑GTC‑AGA‑TTT‑CC‑3′ and NF-κB1 probe
5′-FAM‑CAG‑CCT‑CTG‑TGT‑TTG‑TCC‑AGC‑TTC‑GG-TAMRA‑3′).
mRNA expression was quantified with an ABI 7300 Real-Time
PCR System (Applied Biosystems®) using a TaqMan probe against
endogenous control GAPDH (Pre-developed TaqMan® Assay, Ap-
plied Biosystems®) via the ΔΔct-method. The cycling condition
was set to 50°C for 2min, 95°C for 10min, followed by 40 PCR
cycles of 95°C for 15 s and 60°C for 1min.
NO assay: The inhibition of NO production in vitro in LPS/IFN-γ-
stimulated RAW264.7 cells was determined by the Griess assay
method, as described before [19]. The NO synthase inhibitor NG-
monomethyl-L-arginine (L-NMMA) (100 µM, purity > 99%)
(Alexis Biochemicals) was used as a positive control. The absorb-
ance, which is inversely proportional to the inhibition of NO
production, was determined by a microplate reader (Perkin El-
mer Wallac Victor 1420 Multilabel Counter) at 540 nm.
Leukotriene biosynthesis (5-LOX) inhibition assay: The LOX inhibi-
tion assay was carried out in a 96-well plate format as described
previously [20], with slight modifications. Thirty mL of venous
human blood from healthy volunteer donors were collected by a
physician (Institute of Hygiene, Microbiology and Environmental
Medicine, Medical University of Graz) with a BD Vacutainer® sys-
tem, 9NC 0.129M (BD, Belliver Industrial Estate). Human neutro-
phile granulocytes with 5-LOX activity were isolated from the ve-
nous human blood based on sedimentation rates and lysis toler-
ance.
The cell suspension (4500 cells/mL) was incubated with the sam-
ple, CaCl2, ETYA, Calcium Ionophore A23187, and arachidonic ac-
id in a shaking water bath at 37°C. After 10min, the incubation
was stopped by the addition of 10% formic acid. After centrifuga-
tion, the samples were diluted and the concentration of LTB4
formed during incubation was determined by means of a com-
petitive LTB4 EIA Kit (Cayman Chemical Company). Zileuton
(5 µM, purity > 98.5%) (Sequoia Research Products Ltd.) was used
as a positive control.
COX-1 and COX-2 inhibition assays: The COX-1 and COX-2 assays
were carried out in a 96-well plate format with purified PGHS-1Lajter I et al. Inhibition of COX-2… Planta Med 2015; 81: 1270–1276
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and human recombinant N-terminal hexahistidine-tagged
PGHS-2 isolated from a Baculovirus overexpression system in
Sf21 cells, as reported previously [21,22]. The concentration of
PGE2, the main arachidonic acid metabolite in this reaction, was
determined by a competitive PGE2 EIA kit (Enzo Life Sciences). In-
domethacin (1.25 µM, purity ≥ 99%) and NS-398 (5 µM, purity
≥ 98%) (Cayman Chemical Company) were used as positive con-
trols.
XTT viability assay: The cell proliferation kit II (XTT) (Cat. No. 11
465 015 001) was obtained from Roche Diagnostics. THP-1 cells
were seeded at a density of 2 × 104 cells (100 µL) per well in a
96-well plate and treated in relevant concentrations of 8, 9, and
10 for different time periods (4 h, 24 h, 48 h, 72 h) at 37°C and
5% CO2. After the incubation, the fresh XTT solution [5mL of XTT
soln. (sodium 3-[1(phenylaminocarbonyl)-3,4-tetrazolium]-bis
(4-methoxy-6-nitro)benzene sulfonic acid hydrate), plus 100mL
of electron coupling reagent] was added and analyzed after an-
other 4 h using a microplate reader (TECAN Rainbow) at a wave-
length of 490 nm; the reference wavelength was 650 nm. Vin-
blastine (0.1 μg/mL, purity ≥ 96%) (Sigma-Aldrich) served as a
positive control.
Statistical analysis
Data were analyzed with Graph Pad Prism 4.03 (GraphPad Soft-
ware Inc.) and are given as mean ± standard deviation.Pr
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